The AML Prognostic Marker, AF1q, Is Directly Regulated by MiR-29b

被引：0
|
作者：
Xiong, Yin [1 ]
Li, Zejuan [2 ]
Tan, Aik Choon [1 ]
Bemis, Judson [1 ]
Xie, Xiuyan [3 ]
Bunting, Kevin D. [3 ]
Chen, Jianjun [2 ]
Bemis, Lynne [1 ]
Tse, William [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Denver, CO 80202 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1021 / 1022
页数：2
相关论文
共 50 条
  • [1] AF1q is a novel poor prognostic marker for adult acute myelogenous leukemia (AML) patients with normal cytogenetics
    Strunk, CJ
    Platzbecker, U
    Thiede, C
    Schaich, MA
    Illmer, T
    Kang, ZZ
    Leahy, P
    Li, CB
    Reiner, S
    Laughlin, MJ
    Lazarus, HM
    Bunting, KD
    Gerson, SL
    Ehninger, G
    Tse, WW
    BLOOD, 2005, 106 (11) : 921A - 921A
  • [2] MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML
    Xiong, Yin
    Li, Zejuan
    Ji, Min
    Tan, Aik-Choon
    Bemis, Judson
    Tse, Jove-Victor
    Huang, Gang
    Park, Jino
    Ji, Chunyan
    Chen, Jianjun
    Bemis, Lynne T.
    Bunting, Kevin D.
    Tse, William
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 753 - 757
  • [3] MiR-29b is a Novel Potential Prognostic Marker and Regulates Tumor Progression in Colorectal Cancer
    Inoue, A.
    Yamamoto, H.
    Uemura, M.
    Nishimura, J.
    Hata, T.
    Takemasa, I.
    Ikenaga, M.
    Ikeda, M.
    Murata, K.
    Mizushima, T.
    Doki, Y.
    Mori, M.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S81 - S81
  • [4] MiR-29b is a novel potential prognostic marker and inhibits cell proliferation in colorectal cancer
    Inoue, Akira
    Yamamoto, Hirofumi
    Uemura, Mamoru
    Nishimura, Junichi
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    CANCER RESEARCH, 2014, 74 (19)
  • [5] HIGH EXPRESSION OF AF1Q IS AN ADVERSE PROGNOSTIC FACTOR AND A PREDICTION MARKER OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
    Hagiwara, S.
    Mine, S.
    Schiefer, A. I.
    Kenner, L.
    Tse, W.
    HAEMATOLOGICA, 2016, 101 : 530 - 530
  • [6] Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics
    Strunk, Crawford J.
    Platzbecker, Uwe
    Thiede, Christian
    Schaich, Markus
    Illmer, Thomas
    Kang, Zizhen
    Leahy, Patrick
    Li, Chunbiao
    Xie, Xiuyan
    Laughlin, Mary J.
    Lazarus, Hillard M.
    Gerson, Stanton L.
    Bunting, Kevin D.
    Ehninger, Gerhard
    Tse, William
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 308 - 309
  • [7] miR-29b is a highly promising molecular marker for breast cancer progression
    Papachristopoulou, G.
    Papadopoulos, E. I.
    Rassidakis, G. Z.
    Scorilas, A.
    FEBS JOURNAL, 2015, 282 : 219 - 219
  • [8] Expression of miR-145 and Its Target Proteins Are Regulated by miR-29b in Differentiated Neurons
    Jauhari, Abhishek
    Singh, Tanisha
    Yadav, Sanjay
    MOLECULAR NEUROBIOLOGY, 2018, 55 (12) : 8978 - 8990
  • [9] Expression of miR-145 and Its Target Proteins Are Regulated by miR-29b in Differentiated Neurons
    Abhishek Jauhari
    Tanisha Singh
    Sanjay Yadav
    Molecular Neurobiology, 2018, 55 : 8978 - 8990
  • [10] miR-29b serum levels are down-regulated in patients with neuroendocrine tumors
    Oezdirik, B.
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    Hellberg, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 111 - 111
12345